Latest News & Features
Big Pharma
Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion). 10 January 2018
Asia-Pacific
Southeast Asia-based law firm Tilleke & Gibbins has appointed an IP enforcement specialist to partner. 10 January 2018
Big Pharma
UK-headquartered AstraZeneca and Japanese pharmaceutical company Eisai have urged the UK to remain a member of the European Medicines Agency. 9 January 2018
Americas
Global biopharmaceutical company Celgene Corporation, headquartered in New Jersey, has filed a claim against oncology company Beacon Pharmaceuticals, situated in Bangladesh, for trademark infringement. 9 January 2018
Americas
Celgene Corporation is to acquire Impact Biomedicines in the first quarter of 2018. 9 January 2018
Americas
The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons. 8 January 2018
Americas
The US Court of Appeals for the Federal Circuit has handed Apotex a win in a dispute over a tablet coating. 8 January 2018
Americas
Stanford University has entered into a licensing agreement with Madenco Biosciences to develop and commercialise patented epidermal growth factor wound healing technology. 5 January 2018
Americas
Biotech company Arvinas has announced a multi-year research collaboration and licence agreement with global pharmaceutical corporation Pfizer. 5 January 2018
Americas
Litigation-focused firm Robins Kaplan has promoted nine lawyers so far in 2018, including five IP lawyers in its Silicon Valley, Minneapolis, and Boston offices. 5 January 2018